DXCM

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Dexcom Inc

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
CEO
Kevin Sayer
Employees
5500
Headquarters

6340 Sequence Dr
San Diego, California 92121-4356
Phone: 18582000200
www.dexcom.com

News

Is DexCom (DXCM) Stock Undervalued?
Mar 20, 2023 06:15am

Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returned 5.43% in the quarter compared to a 6.90% return for the Russell Midcap Growth Index. For the full year, the fund […]


Source:Insider Monkey
DexCom Stock Gets A Composite Rating Upgrade After 4 Up Days
Mar 16, 2023 15:14pm

On Thursday, DexCom got an upgrade for its IBD SmartSelect Composite Rating from 94 to 97.


Source:Investor''s Business Daily
DexCom: Riding The Growth Wave
Mar 15, 2023 22:32pm

DexCom has built itself an impressive market position against large competitors in the diabetes space. Click here to read my most recent analysis of DXCM stock.


Source:Seeking Alpha
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today
Mar 15, 2023 16:30pm

DexCom (NASDAQ: DXCM ) has outperformed the market over the past 5 years by 39.53% on an annualized basis producing an average annual return of 46.8%. Currently, DexCom has a market capitalization of $43.20 billion. Buying $1000 In DXCM: If an … Full story available on Benzinga.com


Source:Benzinga
DexCom has no material exposure to SVB
Mar 13, 2023 11:37am

https://www.investing.com/news/assorted/dexcom-has-no-material-exposure-to-svb-432SI-3028902


Source:Investing.com
Surprising stocks: Transocean Ltd. (NYSE:RIG 1.07%), DexCom, Inc. (NASDAQ:DXCM -7.87%)
Mar 07, 2023 13:43pm

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Surprising stocks: Transocean Ltd. (NYSE:RIG 1.07%), DexCom, Inc. (NASDAQ:DXCM -7.87%) appeared first on Stocks Equity .


Source:Stock Equity
What Makes DexCom (DXCM) an Attractive Investment Bet?
Mar 07, 2023 09:59am

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy outperformed its benchmark, the Russell 1000 Growth Index. The strategy gained in seven out of nine sectors it invested in the quarter on […]


Source:Insider Monkey
US stock market closed mixed, Dow Jones up 0.12%
Mar 07, 2023 02:17am

At the close of the New York Stock Exchange, the Dow Jones rose 0.12%, the S&P 500 rose 0.07%, and the NASDAQ Composite fell 0.11%. Markets are also awaiting information from the US labor market, which will be published on Friday. According to market strategist at Nikko Asset Management John Weil, the data for February may turn out to be worse than in January, and this will calm investors a bit in their fears of too sharp tightening of monetary policy. Merck & Company Inc was the top performer among the components of the Dow Jones index today, up 4.22 points or 3.95% to close at 111.10. Apple Inc rose 2.80 points or 1.85% to close at 153.83. Coca-Cola Co rose 0.92 points or 1.55% to close at 60.36. Shares of Dow Inc became the leaders of the fall, the price of which fell by 1.21 points (2.07%), ending the session at 57.11. Walgreens Boots Alliance Inc was up 1.77% or 0.64 points to close at 35.45, while Intel Corporation was down 1.55% or 0.41 points to close at 25. .99 Leading gainers among the components of the S&P 500 in today''s trading were Lumen Technologies Inc, which rose 4.10% to 3.30, Merck & Company Inc, which gained 3.95% to close at 111.10. as well as Enphase Energy Inc, which rose 3.77% to end the session at 225.35.


Source:InstaForex
DexCom drops after Abbott''s diabetes sensors cleared for insulin delivery system integration
Mar 06, 2023 19:39pm

https://www.investing.com/news/stock-market-news/dexcom-drops-after-abbotts-diabetes-sensors-cleared-for-insulin-delivery-system-integration-432SI-3023240


Source:Investing.com
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
Mar 06, 2023 17:18pm

Dexcom stock toppled Monday after the FDA cleared Abbott Laboratories to pair its body-worn glucose monitors with automated insulin pumps.


Source:Investor''s Business Daily
DexCom slips as Abbott wins FDA nod for CGM integration (NASDAQ:DXCM)
Mar 06, 2023 16:32pm

DexCom (DXCM) shares fell Monday after Abbott (ABT) announced the FDA nod for FreeStyle continuous glucose monitoring devices for integration with insulin pumps. Read the full story here.


Source:Seeking Alpha
Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices
Mar 02, 2023 19:04pm

Dexcom stock popped Thursday after CMS said it would cover continuous glucose monitors for a broader group of type 2 diabetics.


Source:Investor''s Business Daily
DexCom rises as Medicare updates coverage for continuous glucose monitors
Mar 02, 2023 19:00pm

DexCom (DXCM) added ~7% Thursday after the Centers for Medicare and Medicaid Services ((CMS)) updated its policy on continuous glucose monitors to expand coverage. Read the full story here.


Source:Seeking Alpha
DexCom shares gain as Medicare to expand CGM coverage in April
Mar 02, 2023 18:44pm

https://www.investing.com/news/stock-market-news/dexcom-shares-gain-as-medicare-to-expand-cgm-coverage-in-april-432SI-3020810


Source:Investing.com
Choosing between riding the trend or protecting profits: DexCom Inc. (DXCM)
Mar 02, 2023 18:00pm

In the current trading session, DexCom Inc.’s (DXCM) stock is trading at the price of $115.77, a gain of 4.52% over last night’s close. So, the stock is trading at a price that is -14.10% less than its 52-week high of $134.76 and 73.07% better than its 52-week low of $66.89. Based on the past […]


Source:US Post News
Here''s How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Mar 02, 2023 17:00pm

DexCom (NASDAQ: DXCM ) has outperformed the market over the past 5 years by 43.33% on an annualized basis producing an average annual return of 50.94%. Currently, DexCom has a market capitalization of $45.30 billion. Buying $1000 In DXCM: If an … Full story available on Benzinga.com


Source:Benzinga
Dexcom Announces Upcoming Conference Presentations
Feb 23, 2023 14:00pm

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: Sean Christensen, Vice President, Finance and Investor Relations, will present on behalf of the company at the Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference on Wednesday, March 1, 2023 at 2:45pm (EST). Jereme Sylvain, Executive


Source:Wallstreet:Online
progress Dexcom Reports on Apple’s Progress in Glucose Tracking
Feb 23, 2023 06:54am

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email A new breakthrough by Apple could be bad news for medical device company Dexcom. With CNBC’s Melissa Lee and the Fast Money traders, Karen Finerman, Dan Nathan, Courtney Garcia and Guy Adami. 03:45 Wed, Feb 22 20236:22 PM EST Source link progress Dexcom Reports on Apple’s Progress in Glucose Tracking


Source:Newslanes
Dexcom Slumps As A New Rival Reportedly Arrives On Scene: Apple
Feb 22, 2023 19:20pm

Dexcom stock slumped Wednesday on a report Apple is working to add a blood glucose monitor to its popular Apple Watch.


Source:Investor''s Business Daily
DexCom on watch on Apple headlines
Feb 22, 2023 17:43pm

https://www.investing.com/news/pro/dexcom-on-watch-on-apple-headlines-432SI-3010894


Source:Investing.com
DexCom: Multiple Catalyst In FY 2023
Feb 16, 2023 16:12pm

DexCom has implemented a bridge program for early adopters and is making steady progress toward its goal of G7 coverage. Click here to read why DXCM stock is a Buy.


Source:Seeking Alpha
Top 5 4th Quarter Trades of Atika Capital Management LLC
Feb 15, 2023 04:00am

Related Stocks: DXCM , PANW , MA , FWONK , AMZN ,


Source:GuruFocus
PayPal, DexCom rise; Expedia, Lyft fall
Feb 10, 2023 21:23pm

Stocks that traded heavily or had substantial price changes Friday: PayPal, DexCom rise; Expedia, Lyft fall


Source:ABC News
As The Stock Rises By 2.90% Year-To-Date, DexCom Inc. (NASDAQ: DXCM)’S Stock Continues To Progress In 2023
Feb 10, 2023 20:00pm

During the recent session, DexCom Inc. (NASDAQ:DXCM)’s traded shares were 2.01 million, with the beta value of the company hitting 1.12. At the last check today, the stock’s price was $116.52, reflecting an intraday gain of 8.65% or $9.28. The 52-week high for the DXCM share is $134.76, that puts it down -15.65 from that … As The Stock Rises By 2.90% Year-To-Date, DexCom Inc. (NASDAQ: DXCM)’S Stock Continues To Progress In 2023 Read More »


Source:Marketing Sentinel
Hot Stocks: SPOT climbs on activist interest; DXCM, AYX rise on earnings; MGA drops
Feb 10, 2023 18:58pm

DXCM and AYX rose on reports of activist interest. DXCM and AYX climbed on earnings news. MGA fell following the release of its quarterly results.


Source:Seeking Alpha
Stock Market On Track For Down Week; Medical Device Stock Shines
Feb 10, 2023 18:55pm

The stock market indexes showed improvement from earlier in the day, but posted mixed results Friday. Dexcom stock was up double-digits.


Source:Investor''s Business Daily
IBD Stock Of The Day Dexcom Bounds Off A New Entry After Topping Bullish Calls
Feb 10, 2023 17:59pm

Dexcom stock is Friday''s IBD Stock Of The Day. Shares are bounding off their 50-day line after the diabetes devices giant beat views.


Source:Investor''s Business Daily
Do you want to know where to find good stock? Take a look at DexCom Inc.’s (NASDAQ:DXCM) Sentiment Analysis
Feb 10, 2023 17:16pm

DexCom Inc. (DXCM)’s stock has witnessed a price hike of 8.90% from the previous close with its current price standing at $116.78. Its current price is -13.35% under its 52-week high of $134.76 and 74.58% more than its 52-week low of $66.89. Based on the past 30-day period, the stock price is -1.12% below the […]


Source:US Post News
DexCom continues earnings boost as it prepares to launch new glucose device; up 10%
Feb 10, 2023 16:55pm

DexCom is up 10% in late Friday morning trading as the continuous glucose monitoring company benefits from quarterly results that beat on the bottom line.


Source:Seeking Alpha
DexCom, Inc. (DXCM) Q4 2022 Earnings Call Transcript
Feb 10, 2023 02:31am

DexCom, Inc. (NASDAQ:NASDAQ:DXCM) Q4 2022 Earnings Conference Call February 9, 2023 4:30 PM ETCompany ParticipantsSean Christensen - Vice President of Finance & Investor RelationsJereme…


Source:Seeking Alpha
DexCom (DXCM) Q4 2022 Earnings Call Transcript
Feb 10, 2023 02:30am

DXCM earnings call for the period ending December 31, 2022.


Source:The Motley Fool
DexCom up 4% in after-hours trading on quarterly bottom line beat
Feb 09, 2023 22:53pm

DexCom (DXCM) is up 4% in after-hours trading after the continuous glucose monitor company saw its Q4 2022 financial results beat on the bottom line.Non-GAAP net income $136.3M ($0.34…


Source:Seeking Alpha
DexCom: Q4 Earnings Snapshot
Feb 09, 2023 21:21pm

SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported fourth-quarter net income of $91.8 million,…


Source:WTOP
Dexcom Advances On Fourth-Quarter Beat, Reiterates Its 2023 Sales Expectations
Feb 09, 2023 21:13pm

Dexcom stock rose late Thursday after beating fourth-quarter expectations and reiterating its 2023 sales outlook.


Source:Investor''s Business Daily
Blood Glucose Meters Global Market Report 2023
Feb 09, 2023 14:55pm

Major players in the blood glucose meters market are Abbott, Roche, Medtronics, Ascensia, Dexcom, Johnson & Johnson, Arkray, Acon, LifeScan, and Agamatrix Inc. The global blood glucose meters market will grow from $15.64 billion in 2022 to $16.96 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. Major players in the blood glucose meters market are Abbott, Roche, Medtronics, Ascensia, Dexcom, Johnson & Johnson, Arkray, Acon, LifeScan, and Agamatrix Inc. The global blood glucose meters market will grow from $15.64 billion in 2022 to $16.96 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%.


Source:GlobeNewswire
A Preview Of DexCom''s Earnings
Feb 08, 2023 18:01pm

DexCom (NASDAQ: DXCM ) is set to give its latest quarterly earnings report on Thursday, 2023-02-09. Here''s what investors need to know before the announcement. Analysts estimate that DexCom will report an earnings per share (EPS) of $0.27. DexCom bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com


Source:Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $49,000 Today
Feb 08, 2023 17:34pm

DexCom (NASDAQ: DXCM ) has outperformed the market over the past 15 years by 22.64% on an annualized basis producing an average annual return of 30.33%. Currently, DexCom has a market capitalization of $42.50 billion. Buying $1000 In DXCM: If an … Full story available on Benzinga.com


Source:Benzinga
DarioHealth announces agreement with DexCom
Feb 08, 2023 13:21pm

DarioHealth (DRIO) has announced an agreement with Dexcom (DXCM), the global leader in real-time continuous glucose monitoring technology, to integrate its market-leading CGMs,…


Source:Seeking Alpha
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
Feb 07, 2023 14:25pm

SAN DIEGO--(BUSINESS WIRE)---- $DXCM #CGM--Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System


Source:Business Wire
Diabetes Deep-Dive With DexCom And Embecta: Polar Opposite Diabetes Plays (NASDAQ:DXCM)
Feb 05, 2023 05:26am

DexCom is young, innovative, and highly valued. Embecta is old, lethargic, and lowly valued. See why I remain on the sidelines of both DXCM and EMBC stocks.


Source:Seeking Alpha
Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom
Feb 02, 2023 12:00pm

TORONTO--(BUSINESS WIRE)--Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital diabetes management solution, to enable convenient on-demand access to Dexcom G6 (NASDAQ: DXCM) real-time continuous glucose monitoring (rtCGM) supplies and personalized diabetes care services. The new integrated Virtual Diabetes Management program combines Mednow virtual pharmacy services with Dexcom


Source:Business Wire
Top 5 4th Quarter Trades of Riverstone Advisors, LLC
Feb 01, 2023 00:00am

Related Stocks: DXCM , TFX , ABT , FSLR , VZ ,


Source:GuruFocus
The Nasdaq 100 Is on a Tear. Here Are 5 Laggards.
Jan 31, 2023 20:56pm

Enphase, Dexcom and O''Reilly are some of the worst performing stocks in the growth-stock index this month.


Source:Barron''s
DexCom Inc. (DXCM) produces promising results
Jan 27, 2023 15:16pm

The share price of DexCom Inc. (NASDAQ:DXCM) rose to $106.65 per share on Thursday from $104.00. While DexCom Inc. has overperformed by 2.55%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DXCM rose by 5.01%, with highs and lows ranging from $134.76 to $66.89, whereas the […]


Source:US Post News
Friday’s Top Analyst Upgrades and Downgrades: Datadog, Las Vegas Sands, Lyft, Nasdaq, Match, Pfizer, Walmart and More
Jan 27, 2023 13:50pm

Friday''s top analyst upgrades and downgrades included Datadog, DexCom, Exelixis, Lam Research, Las Vegas Sands, Lyft, Match, Nasdaq, Next Era Energy, Norfolk Southern, Pfizer, Walmart and Wolfspeed.


Source:24/7 Wall street
DexCom favored as Wolfe launches coverage on diabetes device makers (NASDAQ:DXCM)
Jan 26, 2023 15:15pm

In diabetes device market, Wolfe has granted an Outperform rating for DexCom (DXCM), and Peer Perform ratings for Tandem Diabetes (TNDM) and Insulet (PODD). Read the full story here.


Source:Seeking Alpha
Top 5 4th Quarter Trades of OAK RIDGE INVESTMENTS LLC
Jan 25, 2023 00:00am

Related Stocks: THS , TTGT , DXCM , POOL , BHVN ,


Source:GuruFocus
Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
Jan 24, 2023 14:00pm

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2022 financial results after market close on Thursday, February 9, 2023. Management will hold a conference call to review the company''s fourth quarter and full year 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website a


Source:Business Wire
Procter & Gamble''s Prices, China''s Population, and More
Jan 23, 2023 23:40pm

Plus, Dexcom CEO Kevin Sayer shares some insight on continuous glucose monitors.


Source:The Motley Fool